肺癌低剂量CT筛查的辐射负担与相关癌症风险:一项体模研究
该体模研究采用蒙特卡罗方法估算256层低剂量CT肺癌筛查的单次器官剂量与辐射致癌风险,并估算55-80岁人群每年重复筛查至80岁的累积风险。单次有效剂量为0.71 mSv,定位扫描投影摄影贡献6-12%;单次检查使55岁平均体型男性和女性终生内在癌症风险分别增加0.008%和0.018%,重复年度筛查至80岁累积增加男性0.13%、女性0.30%。
要点
- 肺癌筛查低剂量CT单次有效剂量可低于1 mSv,本研究中为0.71 mSv。
- 定位扫描投影摄影对胸部低剂量CT总有效剂量的贡献为6-12%,剂量评估应纳入。
- 重复年度筛查至80岁的累积辐射致癌风险仅轻微增加终生内在癌症风险。
核心结论
- 现代扫描仪可提供亚毫西弗的肺癌筛查低剂量CT。
- 重复年度256层低剂量CT肺癌筛查的累积辐射风险仅轻微加重典型筛查人群的终生内在癌症风险。
研究设计与样本
- 体模研究,采用蒙特卡罗方法确定肺癌筛查256层低剂量CT中扫描投影摄影和螺旋CT曝光的性别与体型特异性器官剂量数据。
- 估算55-80岁单次256层胸部低剂量CT的终生归因风险,以及从55岁至80岁重复年度低剂量CT的累积终生归因风险,并与相应的终生内在癌症诊断风险比较。
诊断标准与关键数值
- 肺癌筛查256层低剂量CT的有效剂量估计为0.71 mSv。
- 扫描投影摄影对胸部低剂量CT总有效剂量的贡献为6-12%。
- 单次低剂量CT使平均体型55岁男性和女性的终生内在癌症风险分别增加0.008%和0.018%。
- 从55岁至80岁重复年度扫描的累积辐射致癌风险使终生内在癌症风险增加男性0.13%、女性0.30%。
- DLP方法可能低估低剂量胸部CT的有效剂量达27%。
临床应用与阅片要点
- 阅片和报告时可参考本研究中256层低剂量CT肺癌筛查的有效剂量0.71 mSv及定位扫描投影摄影的剂量贡献。
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To estimate (a) organ doses and organ-specific radiation-induced cancer risk from a single low-dose CT (LDCT) for lung cancer screening (LCS) and (b) the theoretical cumulative risk of radiation-induced cancer for a typical cohort to be subjected to repeated annual LCS LDCT.
METHODS: Sex- and body size-specific organ dose data from scan projection radiography (SPR) and helical CT exposures involved in LCS 256-slice LDCT were determined using Monte Carlo methods. Theoretical life attributable risk (LAR) of radiogenic cancer from a single 256-slice chest LDCT at age 55-80 years and the cumulative LAR of cancer from repeated annual LDCT studies up to age 80 years were estimated and compared to corresponding nominal lifetime intrinsic risks (LIRs) of being diagnosed with cancer.
RESULTS: The effective dose from LCS 256-slice LDCT was estimated to be 0.71 mSv. SPR was found to contribute 6-12 % to the total effective dose from chest LDCT. The radiation-cancer LAR from a single LDCT study was found to increase the nominal LIR of cancer in average-size 55-year-old males and females by 0.008 % and 0.018 %, respectively. Cumulative radiogenic risk of cancer from repeated annual scans from the age of 55-80 years was found to increase the nominal LIR of cancer by 0.13 % in males and 0.30 % in females.
CONCLUSION: Modern scanners may offer sub-millisievert LCS LDCT. Cumulative radiation risk from repeated annual 256-slice LDCT LCS examinations was found to minimally aggravate the lifetime intrinsic cancer risk of a typical screening population.
KEY POINTS: • Effective dose from lung cancer screening low-dose CT may be <1 mSv. • Screening with modern low-dose CT minimally aggravates lifetime cancer induction intrinsic risk. • Dosimetry of lung cancer screening low-dose CT should encounter the radiation burden from the localizing scan projection radiography. • DLP method may underestimate effective dose from low-dose chest CT by 27 %.
引用
- Perisinakis K, Seimenis I, Tzedakis A, et al. Radiation burden and associated cancer risk for a typical population to be screened for lung cancer with low-dose CT: A phantom study. Eur Radiol. 2018. PMID: 29651767. doi:10.1007/s00330-018-5373-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。